Showing results (181-190 of 204) with videos related to
Sort By:
Pageof 21
Scientific Reports|March 16, 2025
A comparison of art engagement in museums and through digital mediaKohinoor M Darda, Vicente Estrada Gonzalez, Alexander P Christensen, et al.Brain Stimulation|March 28, 2015
Deep Brain Stimulation Influences Brain Structure in Alzheimer's DiseaseTejas Sankar, M Mallar Chakravarty, Agustin Bescos, et al.Neurobiology of Aging|November 4, 2018
Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 TeslaGeorg Oeltzschner, S Andrea Wijtenburg, Mark Mikkelsen, et al.Journal of Alzheimer'S Disease : JAD|June 21, 2021
Sensitive Measures of Cognition in Mild Cognitive ImpairmentNathaniel Klooster, Stacey Humphries, Eileen Cardillo, et al.Translational Psychiatry|September 14, 2021
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squaresGwenn S Smith, Clifford I Workman, Hillary Protas, et al.Neuroimage|October 8, 2013
Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative populationBrian B Avants, David J Libon, Katya Rascovsky, et al.Acta Neuropathologica|October 31, 2006
Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individualVivianna M Van Deerlin, Mark S Forman, Jennifer M Farmer, et al.Neurobiology of Disease|May 18, 2017
Molecular imaging of serotonin degeneration in mild cognitive impairmentGwenn S Smith, Frederick S Barrett, Jin Hui Joo, et al.Journal of Affective Disorders|October 29, 2020
Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7TGwenn S Smith, Georg Oeltzschner, Neda F Gould, et al.International Journal of Stroke : Official Journal of the International Stroke Society|March 24, 2018
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and designSharon D Yeatts, Joseph P Broderick, Anjan Chatterjee, et al.Pageof 21